70 related articles for article (PubMed ID: 1380887)
1. Down-regulation of tenascin expression by antiprogestins during terminal differentiation of rat mammary tumors.
Vollmer G; Michna H; Ebert K; Knuppen R
Cancer Res; 1992 Sep; 52(17):4642-8. PubMed ID: 1380887
[TBL] [Abstract][Full Text] [Related]
2. Stromal expression of tenascin is inversely correlated to epithelial differentiation of hormone dependent tissues.
Vollmer G; Michna H; Schneider MR; Knuppen R
J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):487-94. PubMed ID: 7514033
[TBL] [Abstract][Full Text] [Related]
3. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
4. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas.
Weckbecker G; Tolcsvai L; Stolz B; Pollak M; Bruns C
Cancer Res; 1994 Dec; 54(24):6334-7. PubMed ID: 7987824
[TBL] [Abstract][Full Text] [Related]
6. Tenascin expression in the human endometrium and in endometrial adenocarcinomas.
Vollmer G; Siegal GP; Chiquet-Ehrismann R; Lightner VA; Arnholdt H; Knuppen R
Lab Invest; 1990 Jun; 62(6):725-30. PubMed ID: 1694256
[TBL] [Abstract][Full Text] [Related]
7. Hormonal induction of casein gene expression limited to a small subpopulation of 7,12-dimethylbenz(a)anthracene-induced mammary tumor cells.
Supowit SC; Rosen JM
Cancer Res; 1982 Apr; 42(4):1355-60. PubMed ID: 6800652
[TBL] [Abstract][Full Text] [Related]
8. Complex expression pattern of tenascin during innervation of the posterior limb buds of the developing chicken.
Martini R; Schachner M
J Neurosci Res; 1991 Feb; 28(2):261-79. PubMed ID: 1709689
[TBL] [Abstract][Full Text] [Related]
9. Tenascin expression in normal and abnormal human endometrium.
Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the distribution patterns of tenascin and alkaline phosphatase in developing teeth, cartilage, and bone of rats and mice.
Väkevä L; Mackie E; Kantomaa T; Thesleff I
Anat Rec; 1990 Sep; 228(1):69-76. PubMed ID: 1700648
[TBL] [Abstract][Full Text] [Related]
11. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
Sylvester PW; Ip C; Ip MM
Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
[TBL] [Abstract][Full Text] [Related]
12. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of estrogen receptor alpha and beta expression in carcinogen-induced mammary gland tumors of rats.
Kang JS; Jung NJ; Kim S; Kim DJ; Jang DD; Yang KH
Eksp Onkol; 2004 Mar; 26(1):31-5. PubMed ID: 15112577
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
15. Tumor-inhibiting potential of ZK 112.993, a new progesterone antagonist, in hormone-sensitive, experimental rodent and human mammary tumors.
Schneider MR; Michna H; Nishino Y; Neef G; el Etreby MF
Anticancer Res; 1990; 10(3):683-7. PubMed ID: 2369083
[TBL] [Abstract][Full Text] [Related]
16. Coordinated induction of cell proliferation and syndecan expression in dental mesenchyme by epithelium: evidence for diffusible signals.
Vainio S; Thesleff I
Dev Dyn; 1992 Jun; 194(2):105-17. PubMed ID: 1384810
[TBL] [Abstract][Full Text] [Related]
17. Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma model.
Robinson SP; Jordan VC
Cancer Res; 1987 Oct; 47(20):5386-90. PubMed ID: 3115568
[TBL] [Abstract][Full Text] [Related]
18. Expression of tenascin in thymus and thymic nonlymphoid cells.
Hemesath TJ; Stefansson K
J Immunol; 1994 Jan; 152(2):422-8. PubMed ID: 7506721
[TBL] [Abstract][Full Text] [Related]
19. Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Boccuzzi G; Aragno M; Brignardello E; Tamagno E; Conti G; Di Monaco M; Racca S; Danni O; Di Carlo F
Anticancer Res; 1992; 12(5):1479-83. PubMed ID: 1444210
[TBL] [Abstract][Full Text] [Related]
20. Hormone dependence of 7,12-dimethylbenz[a]anthracene-induced mammary tumor growth: correlation with prostaglandin E2 content.
Foecking MK; Kibbey WE; Abou-Issa H; Matthews RH; Minton JP
J Natl Cancer Inst; 1982 Aug; 69(2):443-6. PubMed ID: 6810004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
